Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Sponsor: Ascentage Pharma Group Inc.
The purpose of this study is to assess the safety, pharmacokinetic, pharmacodynamic and efficacy of APG-2575 single agent and in combination with other therapeutic agents in patients with relapsed/refractory CLL/SLL.
This description comes directly from the study's public registry record.
Jianyong Li, M.D. · +86-25-83781120 · lijianyonglm@medmail.com.cn
Always discuss trial participation with your own doctor first.
| Peking University Third Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Chongqing Cancer Hospital | Chongqing, Chongqing Municipality, China | Recruiting |
| Nanfang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| Guangxi Medical University Affiliated Tumor Hospital | Nanning, Guangxi, China | Recruiting |
| The Affiliated Hospital of Guizhou Medical University | Guiyang, Guizhou, China | Recruiting |
| The Fourth Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Recruiting |
| Henan Provincial Oncology Hospital | Zhenzhou, Henan, China | Recruiting |
| Union Hospital medical college Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| Xiangya Hospital Central South University | Changsha, Hunan, China | Recruiting |
| The First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| Zhongda Hospital Southeast University | Nanjing, Jiangsu, China | Recruiting |
| The First affiliated hospital of Soochow University | Suzhou, Jiangsu, China | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04494503